chlortetracycline   Click here for help

GtoPdb Ligand ID: 13537

Synonyms: Aureomycin®
Approved drug PDB Ligand
chlortetracycline is an approved drug (FDA (1950))
Compound class: Natural product
Comment: Chlortetracycline is a tetracycline antibacterial, originally isolated from Kitasatospora aureofaciens (formerly Streptomyces aureofaciens), and the first compound from this class to be discovered [3-5]. Note that the structure shown here matches the CAS-assigned structure. The PubChem link, provided in the table below, is to their standardized chemical structure (CID 54675777), although this is not an exact structural match.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 10
Hydrogen bond donors 6
Rotatable bonds 2
Topological polar surface area 181.62
Molecular weight 478.88
XLogP -0.21
No. Lipinski's rules broken 1

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C[C@@]1([C@@]2([H])C[C@@]3([H])[C@@H](C(=C(C(=O)[C@]3(C(=C2C(=O)C4=C1C(=CC=C4O)Cl)O)O)C(=O)N)O)N(C)C)O
Isomeric SMILES O[C@]12[C@]([C@H](N(C)C)C(O)=C(C(N)=O)C1=O)(C[C@]3(C(=C2O)C(=O)C=4C([C@@]3(C)O)=C(Cl)C=CC4O)[H])[H]
InChI InChI=1S/C22H23ClN2O8/c1-21(32)7-6-8-15(25(2)3)17(28)13(20(24)31)19(30)22(8,33)18(29)11(7)16(27)12-10(26)5-4-9(23)14(12)21/h4-5,7-8,15,26,28-29,32-33H,6H2,1-3H3,(H2,24,31)/t7-,8-,15-,21-,22-/m0/s1
InChI Key CYDMQBQPVICBEU-XRNKAMNCSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

References
1. Chopra I, Hawkey PM, Hinton M. (1992)
Tetracyclines, molecular and clinical aspects.
J Antimicrob Chemother, 29 (3): 245-77. [PMID:1592696]
2. Chopra I, Roberts M. (2001)
Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance.
Microbiol Mol Biol Rev, 65 (2): 232-60 ; second page, table of contents. [PMID:11381101]
3. DUGGAR BM. (1948)
Aureomycin; a product of the continuing search for new antibiotics.
Ann N Y Acad Sci, 51 (Art. 2): 177-81. [PMID:18112227]
4. Paine Jr TF, Collins HS, Finland M. (1948)
Bacteriologic Studies on Aureomycin.
J Bacteriol, 56 (4): 489-97. [PMID:16561597]
5. PRICE CW, RANDALL WA, WELCH H. (1948)
Bacteriological studies of aureomycin.
Ann N Y Acad Sci, 51 (Art. 2): 211-7. [PMID:18124196]